List of Chapters/Sections(Table Of Content)
1 Therapeutic Nuclear Medicines Market Overview
1.1 Product Overview and Scope of Therapeutic Nuclear Medicines
1.2 Therapeutic Nuclear Medicines Segment by Type
1.2.1 Global Therapeutic Nuclear Medicines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Therapeutic Nuclear Medicines Segment by Application
1.3.1 Global Therapeutic Nuclear Medicines Sales Comparison by Application: (2021-2027)
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Global Therapeutic Nuclear Medicines Market Size Estimates and Forecasts
1.4.1 Global Therapeutic Nuclear Medicines Revenue 2016-2027
1.4.2 Global Therapeutic Nuclear Medicines Sales 2016-2027
1.4.3 Therapeutic Nuclear Medicines Market Size by Region: 2016 Versus 2021 Versus 2027
2 Therapeutic Nuclear Medicines Market Competition by Manufacturers
2.1 Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Therapeutic Nuclear Medicines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Therapeutic Nuclear Medicines Manufacturing Sites, Area Served, Product Type
2.5 Therapeutic Nuclear Medicines Market Competitive Situation and Trends
2.5.1 Therapeutic Nuclear Medicines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Therapeutic Nuclear Medicines Players Market Share by Revenue
2.5.3 Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Therapeutic Nuclear Medicines Retrospective Market Scenario by Region
3.1 Global Therapeutic Nuclear Medicines Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Therapeutic Nuclear Medicines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Therapeutic Nuclear Medicines Market Facts & Figures by Country
3.3.1 North America Therapeutic Nuclear Medicines Sales by Country
3.3.2 North America Therapeutic Nuclear Medicines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Therapeutic Nuclear Medicines Market Facts & Figures by Country
3.4.1 Europe Therapeutic Nuclear Medicines Sales by Country
3.4.2 Europe Therapeutic Nuclear Medicines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Therapeutic Nuclear Medicines Market Facts & Figures by Region
3.5.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Region
3.5.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Therapeutic Nuclear Medicines Market Facts & Figures by Country
3.6.1 Latin America Therapeutic Nuclear Medicines Sales by Country
3.6.2 Latin America Therapeutic Nuclear Medicines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Therapeutic Nuclear Medicines Market Facts & Figures by Country
3.7.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Country
3.7.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Therapeutic Nuclear Medicines Historic Market Analysis by Type
4.1 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2021)
4.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2016-2021)
4.3 Global Therapeutic Nuclear Medicines Price by Type (2016-2021)
5 Global Therapeutic Nuclear Medicines Historic Market Analysis by Application
5.1 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2021)
5.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2016-2021)
5.3 Global Therapeutic Nuclear Medicines Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Corporation Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis AG Therapeutic Nuclear Medicines Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Bayer Therapeutic Nuclear Medicines Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 China Isotope & Radiation
6.3.1 China Isotope & Radiation Corporation Information
6.3.2 China Isotope & Radiation Description and Business Overview
6.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Product Portfolio
6.3.5 China Isotope & Radiation Recent Developments/Updates
6.4 Q BioMed
6.4.1 Q BioMed Corporation Information
6.4.2 Q BioMed Description and Business Overview
6.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Q BioMed Therapeutic Nuclear Medicines Product Portfolio
6.4.5 Q BioMed Recent Developments/Updates
6.5 Curium Pharmaceuticals
6.5.1 Curium Pharmaceuticals Corporation Information
6.5.2 Curium Pharmaceuticals Description and Business Overview
6.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
6.5.5 Curium Pharmaceuticals Recent Developments/Updates
6.6 Jubilant DraxImage
6.6.1 Jubilant DraxImage Corporation Information
6.6.2 Jubilant DraxImage Description and Business Overview
6.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Product Portfolio
6.6.5 Jubilant DraxImage Recent Developments/Updates
6.7 Dongcheng
6.6.1 Dongcheng Corporation Information
6.6.2 Dongcheng Description and Business Overview
6.6.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Dongcheng Therapeutic Nuclear Medicines Product Portfolio
6.7.5 Dongcheng Recent Developments/Updates
6.8 Lantheus
6.8.1 Lantheus Corporation Information
6.8.2 Lantheus Description and Business Overview
6.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Lantheus Therapeutic Nuclear Medicines Product Portfolio
6.8.5 Lantheus Recent Developments/Updates
6.9 Acrotech Biopharma.
6.9.1 Acrotech Biopharma. Corporation Information
6.9.2 Acrotech Biopharma. Description and Business Overview
6.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Portfolio
6.9.5 Acrotech Biopharma. Recent Developments/Updates
6.10 Progenics Pharmaceuticals
6.10.1 Progenics Pharmaceuticals Corporation Information
6.10.2 Progenics Pharmaceuticals Description and Business Overview
6.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
6.10.5 Progenics Pharmaceuticals Recent Developments/Updates
6.11 International Isotopes
6.11.1 International Isotopes Corporation Information
6.11.2 International Isotopes Therapeutic Nuclear Medicines Description and Business Overview
6.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2016-2021)
6.11.4 International Isotopes Therapeutic Nuclear Medicines Product Portfolio
6.11.5 International Isotopes Recent Developments/Updates
7 Therapeutic Nuclear Medicines Manufacturing Cost Analysis
7.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines
7.4 Therapeutic Nuclear Medicines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Therapeutic Nuclear Medicines Distributors List
8.3 Therapeutic Nuclear Medicines Customers
9 Therapeutic Nuclear Medicines Market Dynamics
9.1 Therapeutic Nuclear Medicines Industry Trends
9.2 Therapeutic Nuclear Medicines Growth Drivers
9.3 Therapeutic Nuclear Medicines Market Challenges
9.4 Therapeutic Nuclear Medicines Market Restraints
10 Global Market Forecast
10.1 Therapeutic Nuclear Medicines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Therapeutic Nuclear Medicines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Therapeutic Nuclear Medicines by Type (2022-2027)
10.2 Therapeutic Nuclear Medicines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Therapeutic Nuclear Medicines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Therapeutic Nuclear Medicines by Application (2022-2027)
10.3 Therapeutic Nuclear Medicines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Therapeutic Nuclear Medicines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Therapeutic Nuclear Medicines by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
